Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Sales are distributed by product family as follows:

- agrochemicals (45.5%): herbicides, fungicides, insecticides, etc.;

- pharmaceutical products (41.2%) : intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc. ;

- OTC products and nutritional supplements (12.6%);

- other (0.7%).

Net sales are distributed geographically as follows: Germany (5.4%), Switzerland (1.2%), Europe-Middle East-Africa (23.7%), the United States (31.1%), North America (3.5%), China (8.6%), Asia-Pacific (11.2%), Brazil (8.1%) and Latin America (7.2%).

Number of employees : 103 824 people.
Sales per Business
2019
EUR (in Million)%
Crop Science19,83245.5%
Pharmaceuticals17,96241.2%
Consumer Health5,46212.5%
All Other Segments277.000.6%
Corporate Functions and Consolidation12.000%
Sales per region
20182019Delta
EUR (in Million)%EUR (in Million)%
United States9,79324.7%13,55631.1% +38.43%
Europe/Middle East/Africa9,87524.9%10,31523.7% +4.46%
Asia/Pacific5,18813.1%4,88511.2% -5.84%
China2,9277.4%3,7268.6% +27.3%
Brazil2,8697.2%3,5398.1% +23.35%
Latin America2,8907.3%3,1247.2% +8.1%
Germany3,8199.6%2,3645.4% -38.1%
North America1,7764.5%1,5313.5% -13.8%
Switzerland449.001.1%505.001.2% +12.47%
Managers
NameAgeSinceTitle
Werner Baumann572016Chairman-Management Board
Norbert Winkeljohann622020Chairman-Supervisory Board
Wolfgang U. Nickl512018Chief Financial Officer
Bijoy Sagar502020Chief Information Technology Officer
Paul Achleitner642002Member-Supervisory Board
Reiner Hoffmann652006Member-Supervisory Board
Oliver Zühlke512015Vice Chairman-Supervisory Board
André van Broich502012Member-Supervisory Board
Petra Reinbold-Knape612012Member-Supervisory Board
Michael Schmidt-Kiessling611981Member-Supervisory Board
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 982,424,082 982,422,097 100.0% 0 0.0% 100.0%
Shareholders
NameEquities%
The Vanguard Group, Inc. 30,282,754 3.08%
Norges Bank Investment Management 29,272,516 2.98%
Harris Associates LP 27,902,083 2.84%
Amundi Asset Management SA (Investment Management) 23,554,050 2.40%
Fidelity Management & Research Co. LLC 18,483,532 1.88%
Massachusetts Financial Services Co. 13,182,047 1.34%
DWS Investments (UK) Ltd. 12,247,989 1.25%
BlackRock Asset Management Deutschland AG 10,377,389 1.06%
Dodge & Cox 9,342,392 0.95%
DWS Investment GmbH 8,897,471 0.91%
Holdings
NameEquities%Valuation
Elanco Animal Health Incorporated (ELAN) 72,946,42915.5%2,037,393,762 USD
Bayer CropScience Limited (506285) 25,344,91756.4%2,022,938,766 USD
Covestro AG (1COV) 13,791,5407.14%684,911,598 USD
Allakos Inc. (ALLK) 4,545,7239.29%370,249,138 USD
CRISPR Therapeutics AG (CRSP) 2,954,7754.21%247,137,381 USD
Evogene Ltd. (EVGN) 1,636,3646.35%7,133,352 USD
Markets and indexes
-
- Prime Standard
- DAX 30 / Euro Stoxx 50, FTSE Eurotop 100, PEA, Stoxx Europe 50, STOXX Europe 600, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  BAYGn:GR
- Reuters Code :  BAYGn.DE
- Datastream Code :  
Company contact information
Bayer AG
Kaiser-Wilhelm Allee 1
DE-51368 Leverkusen, Nordrhein-Westfalen


Phone : +49 214 30 1
Fax :
Internet : https://www.bayer.com/
Brand Portfolio
In partnership withAllbrands.markets
More brands of Bayer AG
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
BAYER AKTIENGESELLSCHAFT-41.27%48 726
JOHNSON & JOHNSON-5.12%376 848
ROCHE HOLDING AG-4.22%283 828
PFIZER INC.-7.96%207 994
MERCK & CO., INC.-16.09%197 256
NOVARTIS AG-19.31%180 257
NOVO NORDISK A/S11.41%159 193
ABBVIE INC.-9.33%145 969
ASTRAZENECA PLC5.90%138 207
BRISTOL-MYERS SQUIBB COMPANY-10.38%132 396
AMGEN INC.-10.05%130 879
SANOFI-9.62%120 434
ELI LILLY AND COMPANY0.11%119 563
GLAXOSMITHKLINE PLC-23.50%88 565
JIANGSU HENGRUI MEDICINE CO., LTD.22.34%70 316
CHUGAI PHARMACEUTICAL CO., LTD.24.38%65 785
ALLERGAN PLC0.97%63 659
TAKEDA PHARMACEUTICAL COMPANY LIMITED-19.46%52 226
DAIICHI SANKYO COMPANY, LIMITED11.65%50 083
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED33.98%26 502
ASTELLAS PHARMA INC.-22.33%25 837